scispace - formally typeset
Open AccessJournal ArticleDOI

Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors' and Longitudinal ‘Targets'

Reads0
Chats0
TLDR
In this article, the leukocyte mRNA expression levels of genes belonging to glucocorticoid receptor (GR) function (FKBP-4, FKBP-5, and GR), inflammatory cytokines (interleukin (IL)-1a, IL-1b), IL-6 and IL-7), macrophage inhibiting factor (MIF), and tumor necrosis factor (TNF)-a), were tested before and after 8 weeks of treatment with escitalopram or nortriptyline, as part of the Genome-
About
This article is published in Neuropsychopharmacology.The article was published on 2013-02-01 and is currently open access. It has received 342 citations till now. The article focuses on the topics: Proinflammatory cytokine.

read more

Citations
More filters
Journal ArticleDOI

Macrophage Migration Inhibitory Factor in Major Depressive Disorder: A Multilevel Pilot Study

TL;DR: In this paper , the potential of MIF at the genetic, expression and protein levels as a risk factor and biomarker to diagnose, monitor, or predict the course of major depressive disorder (MDD) was examined.
Journal ArticleDOI

Macrophage Migration Inhibitory Factor as a Predictor for Long-term Improvements After Mindfulness-Based Group Therapy or Treatment as Usual for Depression, Anxiety or Stress and Adjustment Disorders

TL;DR: Higher MIF levels at baseline were significantly associated with better long-term improvement in psychiatric symptoms, as measured by changes in the Montgomery-Åsberg Depression Rating Scale (MADRS-S), and may serve as a potential biomarker that can guide treatment selection for the personalized treatment for patients with psychiatric disorders.
Journal ArticleDOI

Depression and macrophages: A bibliometric and visual analysis from 2000 to 2022

TL;DR: A literature scan covering the period 2000 to 2022 was performed on macrophages in depression, which were analyzed with Citespace 6.1.1 and VOSviewer 1.6.18 after manual screening, including country publications, institutions, authors, journals, keywords, and references as mentioned in this paper .
References
More filters
Journal ArticleDOI

An inventory for measuring depression

TL;DR: The difficulties inherent in obtaining consistent and adequate diagnoses for the purposes of research and therapy have been pointed out and a wide variety of psychiatric rating scales have been developed.
Journal ArticleDOI

A new depression scale designed to be sensitive to change.

TL;DR: The construction of a depression rating scale designed to be particularly sensitive to treatment effects is described, and its capacity to differentiate between responders and non-responders to antidepressant treatment was better than the HRS, indicating greater sensitivity to change.
Journal ArticleDOI

Development of a Rating Scale for Primary Depressive Illness

TL;DR: This is an account of further work on a rating scale for depressive states, including a detailed discussion on the general problems of comparing successive samples from a ‘population’, the meaning of factor scores, and the other results obtained.
Journal ArticleDOI

A Meta-Analysis of Cytokines in Major Depression

TL;DR: A meta-analysis of studies measuring cytokine concentration in patients with major depression reports significantly higher concentrations of the proinflammatory cytokines TNF-alpha and IL-6 in depressed subjects compared with control subjects, strengthening evidence that depression is accompanied by activation of the IRS.
Journal ArticleDOI

The HPA axis in major depression: classical theories and new developments

TL;DR: It is shown that hyperactivity of the hypothalamic-pituitary-adrenal axis is one of the most consistent biological findings in major depression psychiatry, but the mechanisms underlying this abnormality are still unclear.
Related Papers (5)